Actinogen Medical Limited (ASX:ACW)
Australia · Delayed Price · Currency is AUD 0.0480
+0.0050 (11.63%)
Oct 21, 2026, 4:16 PM AEDT
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of 184.7 million as of October 21, 2026. It is the 23,780th most valuable company in the world and the 492nd biggest in Australia. Its market cap has increased by 87.62% in one year.
Market Cap
184.70M
Enterprise Value
172.75M
Revenue
12.67M
Global Rank
Country Rank
#492 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 12.97M to 184.70M, an increase of 1,323.77%. That is a compound annual growth rate of 14.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 184.70M | -4.99% |
| Dec 31, 2025 | 194.40M | 148.21% |
| Dec 31, 2024 | 78.32M | 54.29% |
| Dec 29, 2023 | 50.76M | -71.90% |
| Dec 30, 2022 | 180.63M | -36.39% |
| Dec 31, 2021 | 283.98M | 832.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Starpharma Holdings | 359.80M |
| Racura Oncology | 302.93M |
| Tetratherix | 284.39M |
| BLS Pharmaceuticals | 238.37M |
| Orthocell | 177.06M |
| Paradigm Biopharmaceuticals | 146.80M |
| Dimerix | 126.08M |
| Nyrada | 106.46M |